Research Project

Project Title:

A multicenter, randomized, double-blind, parallel group, placebo-controlled study to evaluate the efficacy and safety of iptacopan (LNP023) in complement 3 glomerulopathy

Project Type:

Clinical Trial, Enrolment ongoing

Disease group(s):

Hereditary glomerulopathies

Project Summary:

Evaluate the efficacy and safety of iptacopan compared to placebo (and standard of care) in patients with native C3G.

Lead principal investigator(s):

Marina Vivarelli, Rome

Co-investigator(s):

Luca Antonucci, Rome
Antonio Gargiulo, Rome
Chiara Bettini, Rome

Project Period:

11/2021   -   12/2060

EudraCT Nr.:

2020-004589-21

« Back to research page